Neuroone Medical Technologies (NMTC) Shareholder's Equity Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.13% |
| Dec 31, 2025 | 35.37% |
| Sep 30, 2025 | 27.90% |
| Jun 30, 2025 | 32.49% |
| Mar 31, 2025 | 17.26% |
| Dec 31, 2024 | 21.40% |
| Sep 30, 2024 | 21.65% |
| Jun 30, 2024 | 67.07% |
| Mar 31, 2024 | 54.03% |
| Dec 31, 2023 | 23.66% |
| Sep 30, 2023 | 27.89% |
| Jun 30, 2023 | 20.48% |
| Mar 31, 2023 | 23.43% |
| Dec 31, 2022 | 29.36% |
| Sep 30, 2022 | 36.40% |
| Jun 30, 2022 | 142.95% |
| Mar 31, 2022 | 163.54% |
| Dec 31, 2021 | 128.22% |
| Sep 30, 2021 | 129.94% |
| Jun 30, 2021 | 146.48% |
| Mar 31, 2021 | 164.78% |
| Dec 31, 2020 | 80.73% |
| Dec 31, 2019 | -164.86% |
| Jun 30, 2019 | -69.76% |
| Mar 31, 2019 | 166.23% |
| Dec 31, 2018 | -177.20% |
| Sep 30, 2018 | -174.32% |
| Jun 30, 2018 | -209.49% |
| Mar 31, 2018 | -225.34% |
| Dec 31, 2017 | -211.27% |
| Sep 30, 2017 | -194.94% |
| Jun 30, 2017 | -62.90% |
| Mar 31, 2017 | -63.96% |
| Dec 31, 2016 | -140.96% |
| Sep 30, 2016 | -53.97% |
| Jun 30, 2016 | -42.85% |
| Dec 31, 2015 | -79.91% |